Fukushima Chief Dies

Nuclear engineer in charge at Japan’s Fukushima Daiichi power plant during the worst nuclear disaster since Chernobyl dies at age 58.

Written byDan Cossins
| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Tsunami damage at the Fukushima Daiichi power plant WIKIMEDIA, DIGITAL GLOBEMasao Yoshida, the man in charge of the Fukushima Daiichi nuclear power plant in Japan during the disaster wrought by the 2011 tsunami, died of esophageal cancer this week (July 9) at the age of 58. The illness was not believed to be a result of radiation exposure, reported The New York Times.

Yoshida had been chief manager at Fukushima Daiichi for 9 months when the site was engulfed by a 42-foot wave, leading to fuel meltdowns in three reactors and the release of radiation into the environment. He led the recovery efforts from a fortified bunker on the site, where he directed efforts to pump in seawater to cool the reactors.

The NYT reported that in video footage of the command room released last year, Yoshida offered to lead a “suicide mission” to try to pump water into one reactor, only to be dissuaded by colleagues.

While Tokyo Electric Power, the company that operates Fukushima Daiichi, was heavily criticized for its response to the disaster, Yoshida’s efforts to minimize the damage won praise. He did, however, admit ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies